RX-O2 teams with NHSA on brain health research program
RX-O2 Hyperbaric Clinics is launching a brain health research initiative with the National Hyperbaric Safety Association to study hyperbaric oxygen therapy, cognitive function and aging in the greater Phoenix area. The planned program could enroll up to 30 participants and offers discounted therapy for those who qualify through screening.
Why it matters: - The initiative could add new data on whether hyperbaric oxygen therapy affects cognitive function in older adults. - The program is aimed at a common concern in aging: memory loss, mental clarity and broader brain health. - Research participation may also give eligible Phoenix-area adults access to discounted hyperbaric oxygen therapy.
What happened: - RX-O2 Hyperbaric Clinics partnered with the National Hyperbaric Safety Association to develop a Brain Health Research Program. - The program will examine hyperbaric oxygen therapy, cognitive function and aging. - Older adults and families in the greater Phoenix area can contact RX-O2 now to discuss eligibility, screening and possible participation. - The planned cohort includes up to 30 participants. - An inquiry does not reserve a place or count as study enrollment.
The details: - Eligibility will be determined through individual screening. - Interested participants can discuss potential opportunities, costs and participation requirements before making any commitment. - The program may include review of medical records, standardized cognitive assessments and follow-up. - Laboratory testing or imaging may be required. - Some costs may be out of pocket. - RX-O2 says the team will explain those requirements before enrollment decisions are made. - The research team wants to contribute findings for peer-reviewed publication. - The initiative is focused on healthy cognitive aging and cognitive decline associated with Alzheimer's disease and vascular dementia. - People with specific diagnoses must meet the program's research criteria through clinical screening. - HBOT is not an established treatment for preventing cognitive decline or treating dementia, and the program does not promise improvement. - RX-O2 has provided hyperbaric oxygen therapy in the Valley of the Sun for more than 22 years through its Glendale and Scottsdale facilities. - The clinics have treated patients with cognitive concerns, which helped shape interest in more rigorous evidence. - The program also draws inspiration from research affiliated with Israel's Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center and Tel Aviv University's Sagol School of Neuroscience. - A 2020 randomized controlled study of 63 healthy older adults reported improvements in cognitive measures, especially attention and information-processing speed, along with changes in regional brain blood flow. - Those findings involved healthy aging adults and did not establish that HBOT prevents or treats dementia. - Results from this initiative have not yet been published.
Between the lines: - The project is as much about evidence-building as treatment access, with the clinics trying to move from patient anecdotes to structured outcomes. - RX-O2's emphasis on safety and education suggests the program is being framed as a controlled research effort rather than a broad clinical offering. - The collaboration may help the clinic reach adults who are interested in brain health but want clearer guidance on what HBOT can and cannot do. - Marvin A. Borsand, D.O., said observing cognitive decline among peers made the question personal and prompted him to pursue the scientific literature. - Alexander Borsand, M.D., said families deserve clear information about what research suggests, what remains uncertain and what participation requires. - Melanie Dooley, N.D., is serving as a hyperbaric physician and clinical investigator with a focus on measurable outcomes. - Alexander Borsand will support education and safety oversight for the initiative. - He was invited in 2025 to speak about hyperbaric oxygen therapy and cognitive enhancement at an American Academy of Anti-Aging Medicine event.
What's next: - Interested adults and family members in the greater Phoenix area can contact RX-O2 now for screening discussions. - The clinic will review inquiries and explain next steps. - Participants can reach the team through the RX-O2 website, by phone at 480-685-9022 or by email at info@rx-o2.com. - Medical records should be shared only through the clinic's designated secure process. - The research team plans to assess who may benefit, to what extent and under what conditions. - RX-O2 also plans to seek publication of the findings.
The bottom line: - RX-O2 is using a local research program to test a therapy that has drawn interest for brain health but remains unproven for dementia prevention or treatment.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Healthcare Press Releases
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.